# Mobia Medical share price today (Mobia Medical, Inc., MOBI)

> Mobia Medical, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. MOBI · Healthcare · Medical Devices · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/mobi

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $9.97
- Revenue (Jun 2026): $13.5 M (+102.4% on a year ago)
- Profit (Jun 2026), incl. one-off: −$21.0 M (one-off item, see below)
- Operating margin: −132.7% (+24.0 points on a year ago)

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Mobia Medical share price today? Mobia Medical, Inc.'s share price was $9.97 at the close on 3 November 2026. Since its first close in our records, on 15 May 2026, it has traded between $8 and $15, and at that close it sat 29% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 13 weeks running. Over the last 6 months the share price moved −16% while the S&P 500 moved +2%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Mobia Medical pay? Mobia Medical, Inc. pays no dividend. In the last 4 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Mobia Medical on? Mobia Medical is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Mobia Medical profitable? Mobia Medical, Inc. posted a net loss of $21.0 M in the Jun 2026 quarter. That quarter includes a one-off gain bigger than its revenue, so the comparison with last year does not reflect normal business. The full FY25 year was a loss of $46.5 M. That loss is 155.8% of the quarter's revenue. Read this profit with care: at −$21.0 M it is bigger than the quarter's whole revenue of $13.5 M. No business earns more than it takes in from sales, so this is a one-off item (for example a debt settlement, a tax write-back or an asset sale), not money the business earned. The underlying business is running at a −132.7% operating margin. The jump on last year, and any P/E built on this profit, come from the one-off, not from a real turn in earnings. ## How much revenue does Mobia Medical make, and is it growing? Mobia Medical, Inc. reported $13.5 M of revenue in the Jun 2026 quarter, +102.4% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 1 years it has grown 104.8% a year on average. The last full year, FY25, came in at $32.0 M. Recent pace: the last four quarters grew +107.8% on average, against 104.8% a year over the longer run, so this year is growing faster than its own long-run rate. ## How much of every $100 of sales does Mobia Medical keep? Mobia Medical, Inc.'s operating margin was −132.7% in the Jun 2026 quarter, 24.0 percentage points higher than the same quarter a year ago. Across 2 years it has been between −154.9% and −144.7%. Why: the operating margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. ## Is Mobia Medical's profit turning into cash? Mobia Medical, Inc.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 its operations used $45.7 M of cash, against −$46.5 M of profit. After $364 K of spending on assets, free cash was −$46.1 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Mobia Medical's cash go? Mobia Medical, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $405 K on assets over the last 2 years. Averaged over those years that is 0.6% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $405 K over the last 2 years. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is Mobia Medical's P/E ratio, and how does it compare with its own history? Mobia Medical, Inc. has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values Mobia Medical, Inc. at 10.4× its FY25 revenue of $32.0 M. The P/E comes back here once profit turns positive. ## Is the Mobia Medical business getting better or worse? Mobia Medical, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. Why it matters: with too little history, we say so rather than guess a direction. The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Mobia Medical earn on its capital? Mobia Medical, Inc. earned a ROE of −160% in FY25. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a −145.1% net margin and 0.67× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −145.1% net margin × 0.67× asset turnover × 1.66× leverage (assets divided by equity) ≈ −161.4% on equity. The margin does its share; borrowing is a big part of it. ## Does Mobia Medical have too much debt? Mobia Medical, Inc. has total debt of $8.4 M against shareholder equity of $173 M as of Jun 2026, so its debt is 0.05× its equity, which is very little. Year by year, that ratio went from 0.88 in FY24 to 0.29 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Mobia Medical shareholding pattern? 6.2% of Mobia Medical, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 3.2 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Mobia Medical from balance-sheet trouble? For Mobia Medical, Inc., the Z-score is 10.26. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 10.26 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Mobia Medical rank in its industry? There is no score against its industry: Mobia Medical, Inc. is not among the largest members shown in this industry comparison for Medical Devices. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Mobia Medical compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Mobia Medical in size? Mobia Medical is the 64th largest of 75 Medical Devices companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Viemed Healthcare, Inc., Orthofix Medical Inc. and CapsoVision, Inc. Just below it: ClearPoint Neuro, Inc., Quantum-Si incorporated and Treace Medical Concepts, Inc. ### Medical Devices companies close in size

1. [Viemed Healthcare, Inc.](https://www.sectoralpha.in/us/stocks/vmd) $360 million
2. [Orthofix Medical Inc.](https://www.sectoralpha.in/us/stocks/ofix) $357 million
3. [CapsoVision, Inc.](https://www.sectoralpha.in/us/stocks/cv) $335 million
4. Mobia Medical, Inc. $332 million
5. [ClearPoint Neuro, Inc.](https://www.sectoralpha.in/us/stocks/clpt) $311 million
6. [Quantum-Si incorporated](https://www.sectoralpha.in/us/stocks/qsi) $285 million
7. [Treace Medical Concepts, Inc.](https://www.sectoralpha.in/us/stocks/tmci) $278 million

[All 75 Medical Devices companies, largest first](https://www.sectoralpha.in/us/sectors/medical-devices#all-companies)

### Companies close in size in other industries

1. [Community Healthcare Trust Incorporated](https://www.sectoralpha.in/us/stocks/chct) $353 million · REIT - Healthcare Facilities
2. [Eagle Point Credit Company](https://www.sectoralpha.in/us/stocks/ecc) $352 million · Asset Management
3. Mobia Medical, Inc. $352 million
4. [ECARX Holdings Inc.](https://www.sectoralpha.in/us/stocks/ecx) $352 million · Auto Parts
5. [Ranger Energy Services, Inc.](https://www.sectoralpha.in/us/stocks/rngr) $352 million · Oil & Gas Equipment & Services

## What else do people ask about Mobia Medical? ### What is Mobia Medical's stock price today? Mobia Medical, Inc.'s stock price is $9.97. The whole company is worth $332 M on the market. In the last 52 weeks it traded between $8 to $15; today it is 29% of the way up from the low (as of 3 November 2026). ### What were Mobia Medical's latest quarterly results? Mobia Medical, Inc. reported revenue of $13.5 M and a net loss of $21.0 M for the Jun 2026 quarter. Earnings per share were −$1.10. The operating margin was −132.7%, 24.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is Mobia Medical's market cap? Mobia Medical, Inc.'s market capitalisation is $332 M at a stock price of $9.97. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Mobia Medical performing? Mobia Medical, Inc.'s latest readings are below. Over the past 13 weeks it has done worse than the S&P 500, for 13 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Mobia Medical's stock price go up? This page does not forecast Mobia Medical, Inc.'s stock price. What it shows instead: the stock price is $9.97. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Mobia Medical in its business cycle? Mobia Medical, Inc.'s FY25 operating margin was −144.7%, against a 2-year range of −154.9% to −144.7%: the middle of its own range, neither a peak nor a low. The latest quarter was −132.7%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Mobia Medical story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Mobia Medical a stock worth studying right now? What the numbers show: Mobia Medical, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.